Prothena Corporation (PRTA)
NASDAQ: PRTA
· Real-Time Price · USD
5.71
0.63 (12.40%)
At close: Jun 16, 2025, 3:59 PM
5.75
0.79%
After-hours: Jun 16, 2025, 07:40 PM EDT
Prothena Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Collaboration Revenue | 135.11M | 91.32M | 13.86M | 139.83M | 564K |
| Collaboration Revenue Growth | +47.95% | +559.11% | -90.09% | +24693.09% | n/a |
| License Revenue | 50K | 50K | n/a | n/a | 289K |
| License Revenue Growth | 0.00% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17.6M | 16.85M | 16.76M | 15.23M | 17.46M | 16.94M | 16.64M | 14.51M | 13.74M | 13.12M | 11.99M | 12.95M | 11.84M | 12.21M | 11.96M | 11.03M | 11.13M | 9.91M | 9.4M | 9.66M | 9.74M | 8.06M | 8.69M | 9.08M | 9.9M | 8.03M | 9.23M | 10.99M | 14.23M | 14.04M | 12.44M | 10.91M | 10.83M | 9.6M | 16.14M | 8.13M | 7.18M | 6.63M | 5.91M | 5.52M | 5.05M |
| Selling, General, and Administrative Revenue Growth | +4.45% | +0.53% | +10.02% | -12.77% | +3.09% | +1.77% | +14.70% | +5.63% | +4.68% | +9.47% | -7.44% | +9.44% | -3.04% | +2.10% | +8.37% | -0.84% | +12.28% | +5.43% | -2.67% | -0.87% | +20.87% | -7.27% | -4.29% | -8.32% | +23.41% | -13.09% | -15.98% | -22.75% | +1.32% | +12.91% | +13.98% | +0.74% | +12.79% | -40.48% | +98.38% | +13.26% | +8.34% | +12.26% | +6.94% | +9.37% | n/a |
| Research and Development Revenue | 50.81M | 50.17M | 50.72M | 57.51M | 64.11M | 61.89M | 57.91M | 56.01M | 44.76M | 36.87M | 39.86M | 31.57M | 27.26M | 22.06M | 17.99M | 21.09M | 21.14M | 20.76M | 21.61M | 17.27M | 15.25M | 15.47M | 12.49M | 9.58M | 13.3M | 16.51M | 18.52M | 31.45M | 34.71M | 33.5M | 41.31M | 34.03M | 25.7M | 39.84M | 26.84M | 32.36M | 20.49M | 17.89M | 17.18M | 12.79M | 10.57M |
| Research and Development Revenue Growth | +1.27% | -1.09% | -11.80% | -10.30% | +3.59% | +6.87% | +3.40% | +25.15% | +21.39% | -7.50% | +26.26% | +15.80% | +23.59% | +22.60% | -14.69% | -0.26% | +1.85% | -3.91% | +25.09% | +13.27% | -1.44% | +23.91% | +30.29% | -27.93% | -19.47% | -10.83% | -41.13% | -9.38% | +3.59% | -18.91% | +21.40% | +32.43% | -35.50% | +48.46% | -17.06% | +57.90% | +14.55% | +4.10% | +34.35% | +20.98% | n/a |